Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)

In today’s marketplace, there are tons of indicators investors can use to track the equity markets. A couple of the most underrated are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite fund managers can beat the market by a very impressive amount (see just how much).

Equally as necessary, optimistic insider trading activity is another way to look at the marketplace. As the old adage goes: there are many motivations for an insider to get rid of shares of his or her company, but only one, very simple reason why they would initiate a purchase. Various empirical studies have demonstrated the useful potential of this strategy if shareholders understand what to do (learn more here).

Keeping this in mind, let’s discuss the newest info for Warner Chilcott Plc (NASDAQ:WCRX).

What have hedge funds been doing with Warner Chilcott Plc (NASDAQ:WCRX)?

In preparation for the third quarter, a total of 42 of the hedge funds we track held long positions in this stock, a change of 50% from the first quarter. With hedgies’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their stakes meaningfully.

According to our 13F database, Jacob Gottlieb’s Visium Asset Management had the biggest position in Warner Chilcott Plc (NASDAQ:WCRX), worth close to $178.8 million, comprising 4.2% of its total 13F portfolio. Coming in second is AQR Capital Management, managed by Cliff Asness, which held a $112 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Some other hedge funds that hold long positions include Andrew J. M. Spokes’s Farallon Capital, D. E. Shaw’s D E Shaw and Robert Emil Zoellner’s Alpine Associates.

With a general bullishness amongst the titans, certain bigger names were breaking ground themselves. Visium Asset Management, managed by Jacob Gottlieb, created the biggest position in Warner Chilcott Plc (NASDAQ:WCRX). Visium Asset Management had 178.8 million invested in the company at the end of the quarter. Cliff Asness’s AQR Capital Management also made a $112 million investment in the stock during the quarter. The other funds with brand new WCRX positions are Andrew J. M. Spokes’s Farallon Capital, D. E. Shaw’s D E Shaw, and Robert Emil Zoellner’s Alpine Associates.

How have insiders been trading Warner Chilcott Plc (NASDAQ:WCRX)?

Insider buying made by high-level executives is best served when the primary stock in question has experienced transactions within the past six months. Over the latest 180-day time frame, Warner Chilcott Plc (NASDAQ:WCRX) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Warner Chilcott Plc (NASDAQ:WCRX). These stocks are Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY), Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Cubist Pharmaceuticals Inc (NASDAQ:CBST), United Therapeutics Corporation (NASDAQ:UTHR), and Endo Health Solutions Inc (NASDAQ:ENDP). This group of stocks are the members of the drug manufacturers – other industry and their market caps match WCRX’s market cap.